{"id":"W4403454624","doi":"10.1016/j.jacadv.2024.101335","title":"Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity","year":2024,"lang":"en","type":"article","venue":"JACC Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Aspirin; Medicine; Atrial fibrillation; Percutaneous coronary intervention; Limiting; Apixaban; Cardiology; Internal medicine; Antithrombins; Intensive care medicine; Warfarin; Rivaroxaban; Myocardial infarction; Heparin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001224422,0.0002036375,0.0004902713,0.0003316746,0.0002987441,0.0005908861,0.0002144642,0.0001848399,0.002931694],"category_scores_gemma":[0.004433241,0.0001050622,0.001345421,0.0004140782,0.0001228554,0.0002674428,0.000417955,0.000651892,0.00009418056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003140245,"about_ca_system_score_gemma":0.0009294283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001999488,"about_ca_topic_score_gemma":0.005288009,"domain_scores_codex":[0.9991303,0.0004072485,0.0001338648,0.00009594695,0.0001276411,0.0001050127],"domain_scores_gemma":[0.9978539,0.0007704491,0.0008285633,0.00009974065,0.00008479456,0.0003625401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009494813,0.0002074011,0.9583024,0.0001705542,0.002004473,0.0001126407,0.00006417314,0.0003273011,0.0003427537,0.0001680013,0.001036069,0.02776939],"study_design_scores_gemma":[0.0005419906,0.001445725,0.9919398,0.00006294133,0.001705108,0.0003779902,0.0001095979,0.001635459,0.0002675363,0.0004409594,0.001462878,0.000009895845],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924233,0.003917919,0.0003716524,0.001009842,0.00006733231,0.00003714796,0.0006308799,0.00001145894,0.001530356],"genre_scores_gemma":[0.9986902,0.000416022,0.0002673913,0.0001131873,0.00008194593,0.00001893084,0.0001789946,0.000001766893,0.0002316689],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002931694,"threshold_uncertainty_score":0.009807467,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02966600883032382,"score_gpt":0.3268569386952054,"score_spread":0.2971909298648816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}